What's Happening?
Dr. Mary Claire Haver, a prominent OB-GYN and menopause specialist, has joined Midi Health as the 'Chief AgeWell Officer'. Midi Health, a telehealth platform valued at over $1 billion, focuses on women's health and recently closed a $100 million series D funding round. Dr. Haver will lead the company's AgeWell platform, which aims to provide comprehensive care for women's health, including metabolic, bone, and cardiovascular health. Her appointment is part of Midi Health's strategy to expand its proactive, preventative care model for women across the United States.
Why It's Important?
Dr. Haver's appointment at Midi Health highlights the growing recognition and investment in women's health, a sector that has historically been underfunded. Her role is expected to enhance
the company's ability to provide evidence-based, comprehensive care to women, addressing a wide range of health issues beyond menopause. This development could set a new standard for women's healthcare, emphasizing prevention and long-term health management. It also reflects a broader trend of integrating influential health professionals into leadership roles within healthcare startups to drive innovation and improve patient outcomes.
What's Next?
Midi Health plans to leverage Dr. Haver's expertise to expand its services and reach more women across the country. The company may continue to develop its AgeWell platform, incorporating new technologies and treatments to further enhance women's health services. As Midi Health grows, it could influence other healthcare providers to adopt similar models, potentially leading to widespread improvements in women's health care. Additionally, the company's success may attract further investment in the women's health sector, encouraging more innovation and development.
